Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RARγ modulators(Retinoic acid receptor gamma modulators), TNFAIP3 inhibitors(TNF alpha induced protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18O3S |
InChIKeyFEYQNXURJUUZNF-UHFFFAOYSA-N |
CAS Registry2131803-75-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal Squamous Cell Carcinoma | Preclinical | CN | 01 Jan 2025 |